Semorinemab (Anti-Tau)
Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer's disease. MW : 150 kD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2693 |
| Sku # | A2693-1mg*5 |
| Pricing | 1mg*5, $970.00 |